MNTS
Momentus Inc.
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
News Summary
NegativeMomentus reported Q2 2026 revenue of only $25k against expectations of $2M+ quarterly run rate, representing a significant miss and suggesting the Q1 acceleration was temporary rather than sustainable. While the company secured $76M in cash through capital raises and achieved operational milestones (Vigoride 7/8 progress, new LASP contract), the massive dilutive equity offerings and revenue collapse overshadow these positives, with stock down 27% post-placement and trading near 52-week lows.
Red flags
- •Q2 2026 revenue of $25k dramatically missed analyst expectations of $2M+ quarterly sustained run rate
- •27% stock decline following $25M equity offering due to dilution concerns
- •Net loss of $8.27M in Q2 despite minimal revenue generation
- •Stock trading near 52-week low of $3.11 versus $43.55 high, indicating severe investor confidence erosion
- •Multiple dilutive capital raises ($25M + $76M) in short timeframe suggesting cash burn remains acute despite claimed balance sheet strengthening
Fund 13D/13G Filings (2)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Citadel Advisors | SC 13G/A | −326K | 1.6% | -12.9% vs SPY -14.7% abs | 2026-08-14 | ↗ |
| Citadel Advisors | SC 13G | NEW | 10.0% | — | 2026-04-22 | ↗ |